MBCCOP - University of Illinois at Chicago — Chicago, Illinois

MBCCOP - University of Illinois at Chicago is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

MBCCOP - University of Illinois at Chicago has participated in 74 clinical trials.

Therapeutic areas: Cervical Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer.

Sponsors: Gynecologic Oncology Group, SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MBCCOP - University of Illinois at Chicago?

MBCCOP - University of Illinois at Chicago has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MBCCOP - University of Illinois at Chicago conducted?

MBCCOP - University of Illinois at Chicago has 74 clinical trials on record. Their work covers Cervical Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer.

Is MBCCOP - University of Illinois at Chicago accredited by Crixeo Health?

MBCCOP - University of Illinois at Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MBCCOP - University of Illinois at Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.